FIELD: medicine.
SUBSTANCE: method involves administering suspension containing up to 500 thousand of fibroblasts introduced on 50 to 400 mcm large microspheres as injections into connective tissue.
EFFECT: enhanced effectiveness in treating for periodontitis, age-specific skin defects, fistulas, wounds and ureteral reflux.
4 cl
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITION FOR CELL-REPLACEMENT THERAPY OF SOFT TISSUE DEFECTS | 2013 |
|
RU2522816C1 |
| BIOACTIVE COMPLEX FOR ORGANOGENESIS | 2003 |
|
RU2254146C2 |
| METHOD OF TREATING PERIODONTITIS | 2010 |
|
RU2440060C1 |
| BIOTRANSPLANT, METHOD OF ITS OBTAINING AND METHOD OF TREATING PERIODONTAL DISEASES | 2009 |
|
RU2418571C1 |
| METHOD FOR CORRECTION OF AGE-RELATED SKIN CHANGES | 2009 |
|
RU2380106C1 |
| BIOTRANSPLANT FOR CORRECTION OF SOFT TISSUE DEFECTS (VERSIONS), METHOD OF BIOTRANSPLANT OBTAINING (VERSIONS) AND METHOD OF CORRECTION OF SOFT TISSUE DEFECTS | 2009 |
|
RU2428996C2 |
| METHOD FOR SURGICAL TREATING INFLAMMATORY-DESTRUCTIVE PARODONTIUM DISEASES | 2002 |
|
RU2231986C1 |
| METHOD FOR MAKING A BIOTRANSPLANT, A BIOTRANSPLANT FOR ELIMINATING GINGIVAL RECESSIONS AND RECOVERING A LOST GUM VOLUME, A METHOD OF ELIMINATING GINGIVAL RECESSIONS AND RECOVERING A LOST GUM VOLUME | 2018 |
|
RU2700510C1 |
| METHOD FOR TREATMENT OF PATIENTS WITH CONGENITAL EPIDERMOLYSIS BULLOSA BY COMBINED USE OF HUMAN ALLOGENEIC FIBROBLASTS AND LIVING SKIN EQUIVALENT | 2020 |
|
RU2779997C2 |
| BIOTRANSPLANT AND METHOD FOR CORRECTION OF SOFT TISSUE DEFECT, METHOD FOR PREPARING BIOTRANSPLANT | 2005 |
|
RU2281776C1 |
